Journal Article

A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients

Manfrin, Andrea, Thomas, Trudy, Krska, Janet, Tinelli, Michela

2017

Overview

Background The economic burden of asthma, which relates to the degree of control, is €5 billion annually in Italy. Pharmacists could help improve asthma control, reducing this burden. This study aimed to evaluate the effectiveness and cost-effectiveness of Medicines Use Reviews provided by community pharmacists in asthma. Methods This cluster randomised, multi-centre, controlled trial in adult patients with asthma was conducted in 15 of the 20 regions of Italy between September 2014 and July 2015. After stratification by region, community pharmacists were randomly allocated to group A (trained in and delivered the intervention at baseline) or B (training and delivery 3 months later), using computerised random number generation in blocks of 10. Each recruited up to five patients, with both groups followed for 9 months. The intervention consisted of a systematic, structured face-to-face consultation with a pharmacist, covering asthma symptoms, medicines used, attitude towards medicines and adherence, recording pharmacist-identified pharmaceutical care issues (PCIs). The primary outcome was asthma control, assessed using the Asthma-Control-Test (ACT) score (ACT ≥ 20 represents good control). Secondary outcomes were: number of active ingredients, adherence, cost-effectiveness compared with usual care. Although blinding was not possible for either pharmacists or patients, assessment of outcomes was conducted by researchers blind to group allocation. Results Numbers of pharmacists and patients enrolled were 283 (A = 136; B = 147) and 1263 (A = 600; B = 663), numbers completing were 201 (A = 97; B = 104) and 816 (A = 400; B = 416), respectively. Patients were similar in age and gender and 56.13% (458/816) had poor/partial asthma control. Pharmacists identified 1256 PCIs (mean 1.54/patient), mostly need for education, monitoring and potentially ineffective therapy. Median ACT score at baseline differed between groups (A = 19, B = 18; p  < 0.01). Odds ratio for improved asthma control was 1.76 (95% CI 1.33–2.33) and number needed to treat 10 (95% CI 6–28). Number of active ingredients reduced by 7.9% post-intervention ( p  < 0.01). Adherence improved by 35.4% 3 months post-intervention and 40.0% at 6 months ( p  < 0.01). The probability of the intervention being more cost-effective than usual care was 100% at 9 months. Conclusions This community pharmacist-based intervention demonstrated both effectiveness and cost-effectiveness. It has since been implemented as the first community pharmacy cognitive service in Italy. Trial registration TRN: ISRCTN72438848 (registered 5 th January 2015, retrospectively).

• Publisher: BioMed Central,Springer Nature B.V,BMC
• Subject: Adolescent / Adult / Aged / Aged, 80 and over / Anti-Asthmatic Agents - economics / Anti-Asthmatic Agents - therapeutic use / Asthma / Asthma - drug therapy / Asthma - economics / Asthma control / Cluster Analysis / Community pharmacy / Community Pharmacy Services - economics / Cost analysis / Cost-Benefit Analysis / Cost-effectiveness / Data collection / Drug stores / Drug Utilization Review / Effectiveness / Evidence-based medicine / Female / Health Administration / Health care expenditures / Health Informatics / Health services / Humans / Intervention / Italy / Male / Medicine / Medicine & Public Health / Medicines use review / Middle Aged / Nursing Research / Patients / Pharmaceuticals / Pharmacies - economics / Pharmacists / Pharmacists - economics / Primary care / Public Health / Quality / Quality of life / Recruitment / Referral and Consultation / Research Article / Research methodology / safety and outcomes / Young Adult